Broad-spectrum Neutralization of Avian Influenza Viruses by Sialylated Human Milk Oligosaccharides: in Vivo Assessment of 3'-sialyllactose Against H9N2 in Chickens

Overview

Journal Sci Rep

Specialty Science

Date 2018 Feb 9

PMID 29416087

Citations 16

Authors

Ramesh Prasad Pandey

Dae Hee Kim

Jinsuk Woo

Jaeyoung Song

Sang Ho Jang

Joon Bae Kim

Kwang Myun Cheong

Jin Sik Oh

Jae Kyung Sohng

Affiliations

Soon will be listed here.

Abstract

Two sialylated human milk oligosaccharides (SHMOs) 3'-sialyllactose (3'-SL) and 6'-sialyllactose (6'-SL) were accessed for their possible antiviral activity against six different subtypes of thirteen avian influenza (AI) viruses in vitro. 3'-SL exhibited promising antiviral activity against almost all subtypes of tested AI viruses in hemagglutination inhibition assay, whereas 6'-SL showed activity against few selected H1N1, H1N2, and H3N2 subtype strains. 3'-SL has minimum inhibitory concentration values of 15.62 mM or less in more than half of the viruses examined. 3'-SL also showed effective inactivation of H9N2 Korea isolate (A/Chicken/Korea/MS96/1996) at 12.5 mM concentration in Madin Darby Canine Kidney (MDCK) cell line. Thus, 3'-SL was further studied for in vivo study against H9N2 virus in pathogen free chicken experiment models. In vivo study exhibited improved clinical symptoms on H9N2 infected chickens when treated with 3'-SL. Moreover, treating chickens with 3'-SL resulted in complete elimination of H9N2 viruses within 24 h of virus infection (0.8 HAU of H9N2). Indirect ELISA assay confirmed complete wash-out of H9N2 viruses from the colon after neutralization by 3'-SL without entering the blood stream. These in vivo results open up possible applications of 3'-SL for the prevention of AI virus infections in birds by a simple cleansing mechanism.

Citing Articles

Biological effects of combinations of structurally diverse human milk oligosaccharides.

Wichmann A Front Pediatr. 2024; 12:1439612.

PMID: 39564380 PMC: 11573541. DOI: 10.3389/fped.2024.1439612.

Sialic acids in infection and their potential use in detection and protection against pathogens.

Dedola S, Ahmadipour S, de Andrade P, Baker A, Boshra A, Chessa S RSC Chem Biol. 2024; 5(3):167-188.

PMID: 38456038 PMC: 10915975. DOI: 10.1039/d3cb00155e.

Enhancing immune regulation : the synergistic impact of 3'-sialyllactose and osteopontin in a nutrient blend following influenza virus infection.

Guo Z, Xie Q, Ren Q, Liu Y, Li K, Li B Front Immunol. 2024; 15:1271926.

PMID: 38426086 PMC: 10902112. DOI: 10.3389/fimmu.2024.1271926.

Targeting host-virus interactions: in silico analysis of the binding of human milk oligosaccharides to viral proteins involved in respiratory infections.

Mahaboob Ali A, Vishal A, Nelson E Sci Rep. 2024; 14(1):4111.

PMID: 38374384 PMC: 10876934. DOI: 10.1038/s41598-024-54624-6.

Viruses and Human Milk: Transmission or Protection?.

Francese R, Peila C, Donalisio M, Lamberti C, Cirrincione S, Colombi N Adv Nutr. 2023; 14(6):1389-1415.

PMID: 37604306 PMC: 10721544. DOI: 10.1016/j.advnut.2023.08.007.

References

Velkov T . The specificity of the influenza B virus hemagglutinin receptor binding pocket: what does it bind to?. J Mol Recognit. 2013; 26(10):439-49. DOI: 10.1002/jmr.2293. View

Stevens J, Blixt O, Paulson J, Wilson I . Glycan microarray technologies: tools to survey host specificity of influenza viruses. Nat Rev Microbiol. 2006; 4(11):857-64. PMC: 7097745. DOI: 10.1038/nrmicro1530. View

Childs R, Palma A, Wharton S, Matrosovich T, Liu Y, Chai W . Receptor-binding specificity of pandemic influenza A (H1N1) 2009 virus determined by carbohydrate microarray. Nat Biotechnol. 2009; 27(9):797-9. PMC: 3771066. DOI: 10.1038/nbt0909-797. View

Sokurenko E, Chesnokova V, Doyle R, Hasty D . Diversity of the Escherichia coli type 1 fimbrial lectin. Differential binding to mannosides and uroepithelial cells. J Biol Chem. 1997; 272(28):17880-6. DOI: 10.1074/jbc.272.28.17880. View

Zhang W, Shi Y, Qi J, Gao F, Li Q, Fan Z . Molecular basis of the receptor binding specificity switch of the hemagglutinins from both the 1918 and 2009 pandemic influenza A viruses by a D225G substitution. J Virol. 2013; 87(10):5949-58. PMC: 3648181. DOI: 10.1128/JVI.00545-13. View

Yang J, Shun C, Chien C, Wang T . Effective prevention and treatment of Helicobacter pylori infection using a combination of catechins and sialic acid in AGS cells and BALB/c mice. J Nutr. 2008; 138(11):2084-90. DOI: 10.3945/jn.108.090985. View

Ten Bruggencate S, Bovee-Oudenhoven I, Feitsma A, van Hoffen E, Schoterman M . Functional role and mechanisms of sialyllactose and other sialylated milk oligosaccharides. Nutr Rev. 2014; 72(6):377-89. DOI: 10.1111/nure.12106. View

Lee D, Song C . H9N2 avian influenza virus in Korea: evolution and vaccination. Clin Exp Vaccine Res. 2013; 2(1):26-33. PMC: 3623497. DOI: 10.7774/cevr.2013.2.1.26. View

Sharon N . Carbohydrates as future anti-adhesion drugs for infectious diseases. Biochim Biophys Acta. 2006; 1760(4):527-37. DOI: 10.1016/j.bbagen.2005.12.008. View

10.

Ronnestad A, Abrahamsen T, Medbo S, Reigstad H, Lossius K, Kaaresen P . Late-onset septicemia in a Norwegian national cohort of extremely premature infants receiving very early full human milk feeding. Pediatrics. 2005; 115(3):e269-76. DOI: 10.1542/peds.2004-1833. View

11.

Coppa G, Zampini L, Galeazzi T, Facinelli B, Ferrante L, Capretti R . Human milk oligosaccharides inhibit the adhesion to Caco-2 cells of diarrheal pathogens: Escherichia coli, Vibrio cholerae, and Salmonella fyris. Pediatr Res. 2006; 59(3):377-82. DOI: 10.1203/01.pdr.0000200805.45593.17. View

12.

Han Z, Pinkner J, Ford B, Obermann R, Nolan W, Wildman S . Structure-based drug design and optimization of mannoside bacterial FimH antagonists. J Med Chem. 2010; 53(12):4779-92. PMC: 2894565. DOI: 10.1021/jm100438s. View

13.

Stevens J, Blixt O, Tumpey T, Taubenberger J, Paulson J, Wilson I . Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science. 2006; 312(5772):404-10. DOI: 10.1126/science.1124513. View

14.

Li C, Yu K, Tian G, Yu D, Liu L, Jing B . Evolution of H9N2 influenza viruses from domestic poultry in Mainland China. Virology. 2005; 340(1):70-83. DOI: 10.1016/j.virol.2005.06.025. View

15.

Kwon H, Cho S, Kim M, Ahn Y, Kim S . Molecular epizootiology of recurrent low pathogenic avian influenza by H9N2 subtype virus in Korea. Avian Pathol. 2006; 35(4):309-15. DOI: 10.1080/03079450600821166. View

16.

Takahashi K, Ohashi K, Abe Y, Mori S, Taniguchi K, Ebina T . Protective efficacy of a sulfated sialyl lipid (NMSO3) against human rotavirus-induced diarrhea in a mouse model. Antimicrob Agents Chemother. 2002; 46(2):420-4. PMC: 127020. DOI: 10.1128/AAC.46.2.420-424.2002. View

17.

Spackman E, Senne D, Myers T, Bulaga L, Garber L, Perdue M . Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes. J Clin Microbiol. 2002; 40(9):3256-60. PMC: 130722. DOI: 10.1128/JCM.40.9.3256-3260.2002. View

18.

Ukkonen P, Varis K, Jernfors M, Herva E, Jokinen J, Ruokokoski E . Treatment of acute otitis media with an antiadhesive oligosaccharide: a randomised, double-blind, placebo-controlled trial. Lancet. 2000; 356(9239):1398-402. DOI: 10.1016/S0140-6736(00)02843-9. View

19.

Park K, Kwon H, Song M, Pascua P, Baek Y, Lee J . Rapid evolution of low-pathogenic H9N2 avian influenza viruses following poultry vaccination programmes. J Gen Virol. 2010; 92(Pt 1):36-50. DOI: 10.1099/vir.0.024992-0. View

20.

Martin-Sosa S, Martin M, Hueso P . The sialylated fraction of milk oligosaccharides is partially responsible for binding to enterotoxigenic and uropathogenic Escherichia coli human strains. J Nutr. 2002; 132(10):3067-72. DOI: 10.1093/jn/131.10.3067. View